R&D Systems™ Recombinant Cynomolgus/Rhesus Macaque BTLA Fc Protein

Catalog No.	Quantity
10-030-BT050	50 μg

Catalog No. 10-030-BT050 Supplier R&D Systems™ Supplier No. 10030BT050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its binding ability in a functional ELISA. When Recombinant Mouse HVEM/TNFRSF14 Fc Chimera (Catalog # 2516-HV ) is immobilized at 0.5 μg/mL, Recombinant Cynomolgus Monkey BTLA Fc Chimera binds with an ED50 of 25-125 ng/mL.

Specifications

• Accession Number: XP_005548224
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 151888
• Molecular Weight (g/mol): M.W. (Observed): 48-58 kDa, reducing conditions; M.W. (theoretical): 40.3 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived BTLA protein Cynomolgus Monkey BTLA (Met1-Leu150) (N-terminus) Accession # XP_005548224 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Specific Reactivity: BTLA/CD272
• Conjugate: Unconjugated
• Species: Cynomolgus Monkey, Rhesus macaque
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: BTLA/CD272